Association Between Spinal Manipulative Therapy for Low Back Pain With or Without Sciatica and Opioid Use Disorder: A
Robert J Trager1,2,3, Zachary A Cupler4, Jordan A Gliedt5
1Connor Whole Health University Hospitals Cleveland Medical Center Cleveland Ohio USA.
Health Science Reports
|September 22, 2025
Summary
Patients receiving spinal manipulative therapy (SMT) for low back pain (LBP) had a significantly lower risk of developing opioid use disorder (OUD) compared to those prescribed ibuprofen. This study highlights SMT as a potentially safer alternative for LBP management.
Area of Science:
- Pain Management
- Integrative Medicine
- Public Health
Background:
- Previous research indicates spinal manipulative therapy (SMT) for low back pain (LBP) may reduce opioid prescription rates.
- The clinical significance of this association regarding opioid use disorder (OUD) development remains unclear.
Purpose of the Study:
- To test the hypothesis that opioid-naïve adults receiving SMT for LBP are less likely to develop OUD compared to matched controls prescribed ibuprofen.
- To investigate the long-term implications of SMT versus ibuprofen for LBP management in relation to opioid use.
Main Methods:
- A retrospective cohort study using the TriNetX United States data resource.
- Propensity score matching was employed to compare patients receiving SMT for new LBP episodes with those prescribed ibuprofen, controlling for OUD risk factors.
- Primary outcome was the risk ratio (RR) for OUD, with secondary outcomes including long-term opioid use and opioid prescription rates over a 2-year follow-up period.
Main Results:
- The study included 24,993 patients per cohort after matching.
- SMT recipients demonstrated a significantly lower risk of OUD (RR=0.20), long-term opioid use (RR=0.23), and any opioid prescription (RR=0.69) compared to the ibuprofen cohort.
- SMT patients received fewer opioid prescriptions on average (1.0 vs. 2.1).
Conclusions:
- Adults treated with SMT for new LBP exhibited a reduced risk of developing OUD compared to those managed with ibuprofen.
- These findings support current guidelines recommending SMT as a first-line treatment for LBP.
- Further research is warranted to explore the role of SMT in mitigating opioid-related harms.
Related Concept Videos
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners
865
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
865
Opioid Analgesics: Synthetic and Semisynthetic Opioids
931
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
931


